Risk of major adverse cerebro-cardiovascular events following BNT162b2, CoronaVac, and ChAdOx1 vaccination and SARS-CoV-2 infection: A self-controlled case-series study
Norazida Ab Rahman(Hospital Kuala Lumpur), Sheamini Sivasampu(Ministry of Health), Teck Long King(Sarawak General Hospital), Kalaiarasu M. Peariasamy(Ministry of Health)
Cited by 4
Related Papers
Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis
|The Lancet Digital Health|2022|178
Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study
|The Lancet Regional Health - Western Pacific|2020|132
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities
|JAMA Internal Medicine|2022|105
Influence of Population Density for COVID-19 Spread in Malaysia: An Ecological Study
|International Journal of Environmental Research and Public Health|2021|85
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
|International Journal of Infectious Diseases|2022|79